Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts
Identificadores
URI: https://hdl.handle.net/10481/85533Metadatos
Afficher la notice complèteEditorial
Elsevier
Materia
Cancer Cohort Colorectal cancer Risk Serum calcium
Date
2022-12-15Referencia bibliográfica
The American Journal of Clinical Nutrition 117 (2023) 33–45
Patrocinador
John Latsis Public Benefit Foundation; International Agency for Research on Cancer; Krebsforschung Schweiz KFS-4114-02-2017; Health Research Board - Ireland HRA-POR/2013/397; German Research Foundation (DFG) FOR-2558 Scho 849/6-1; Health Research Council of New Zealand Sir Charles Hercus Health Research Fellowship from the Health Research Council of New Zealand; Cancer Research UK; Wellcome Trust; World Health Organization International Agency for Research on Cancer (IARC); Department of Epidemiology and Biostatistics; UK Research & Innovation (UKRI) Medical Research Council UK (MRC) MR/N003284/1 MC-UU_12015/1; Cancer Research UK C864/A14136; Danish Cancer Society (Denmark); Ligue Contre le Cancer (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Gustave Roussy (France); Deutsche Krebshilfe German Cancer Aid (Germany); German Cancer Research Center (DKFZ) (Germany); German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) (Germany); Federal Ministry of Education and Research (BMBF) (Germany); Fondazione AIRC per la ricerca sul cancro; Compagnia di San Paolo; Consiglio Nazionale delle Ricerche (CNR); Netherlands Government Dutch Ministry of Public Health, Welfare and Sports (VWS) (The Netherlands); Health Research Fund (FIS) -Instituto de Salud Carlos III (ISCIII) (Spain); Junta de Andalucia Regional Government of Andalucia (Spain); Principality of Asturias Regional Government of Asturias (Spain); Regional Government of Basque Country (Spain); Regional Government of Murcia (Spain); Regional Government of Navarra (Spain); Catalan Institute of Oncology -ICO (Spain); Swedish Cancer Society; Region Skane (Sweden); Region Vasterbotten (Sweden); UK Research & Innovation (UKRI) Medical Research Council UK (MRC) 1000143 MR/M012190/1; Cancer Research UK (United Kingdom) C8221/A29017 14136; Health Research Board - Ireland HRA-POR-2013-397Résumé
Background
Higher dietary calcium consumption is associated with lower colorectal cancer (CRC) risk. However, little data are available on the association between circulating calcium concentrations and CRC risk.
Objectives
To explore the association between circulating calcium concentrations and CRC risk using data from 2 large European prospective cohort studies.
Methods
Conditional logistic regression models were used to calculate multivariable-adjusted ORs and 95% CIs in case-control studies nested within the European Prospective Investigation into Cancer and Nutrition (EPIC; n-cases = 947, n-controls = 947) and the UK Biobank (UK-BB; n-cases = 2759, n-controls = 12,021) cohorts.
Results
In EPIC, nonalbumin-adjusted total serum calcium (a proxy of free calcium) was not associated with CRC (OR: 0.94; 95% CI: 0.85, 1.03; modeled as continuous variable, per 1 mg/dL increase), colon cancer (OR: 0.93; 95% CI: 0.82, 1.05) or rectal cancer (OR: 1.01; 95% CI: 0.84, 1.20) risk in the multivariable adjusted model. In the UK-BB, serum ionized calcium (free calcium, most active form) was inversely associated with the risk of CRC (OR: 0.85; 95% CI: 0.76, 0.95; per 1 mg/dL) and colon cancer (OR: 0.78; 95% CI: 0.68, 0.90), but not rectal cancer (OR: 1.02; 95% CI: 0.83, 1.24) in multivariable adjusted models. Meta-analysis of EPIC and UK-BB CRC risk estimates showed an inverse risk association for CRC in the multivariable adjusted model (OR: 0.90; 95%CI: 0.84, 0.97). In analyses by quintiles, in both cohorts, higher levels of serum calcium were associated with reduced CRC risk (EPIC: ORQ5vs.Q1: 0.69; 95% CI: 0.47, 1.00; P-trend = 0.03; UK-BB: ORQ5vs.Q1: 0.82; 95% CI: 0.72, 0.94; P-trend < 0.01). Analyses by anatomical subsite showed an inverse cancer risk association in the colon (EPIC: ORQ5vs.Q1: 0.63, 95% CI: 0.39, 1.02; P-trend = 0.05; UK-BB: ORQ5vs.Q1: 0.75; 95% CI: 0.64, 0.88; P-trend < 0.01) but not the rectum.
Conclusions
In UK-BB, higher serum ionized calcium levels were inversely associated with CRC, but the risk was restricted to the colon. Total serum calcium showed a null association in EPIC. Additional prospective studies in other populations are needed to better investigate these associations.